University of Kentucky-Gill Heart Institute

Lexington, Kentucky 40536

1 studies enrolling now · 7 studies all time

What they study most

Acute Pulmonary Embolism, Atrial Fibrillation, Coronary Artery Disease (CAD), Ischemic Heart Failure, Massive Pulmonary Embolism, Myocardial Infarction, Pulmonary Embolism, Pulmonary Thromboembolism, ST Segment Elevation Myocardial Infarction, Sub-massive Pulmonary Embolism, Sudden Death, Transthyretin Amyloidosis (ATTR) With Cardiomyopathy

Studies at this site

• MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM) — Recruiting now
• Submassive and Massive Pulmonary Embolism Treatment With Ultrasound Accelerated Thrombolysis Therapy — Completed
• Vest Prevention of Early Sudden Death Trial and VEST Registry — Completed
• Evaluation of M118 in Percutaneous Coronary Intervention (EMINENCE) — Completed
• Study Of The Blood Thinner, Apixaban, For Patients Who Have An Abnormal Heart Rhythm (Atrial Fibrillation) And Expected To Have Treatment To Put Them Back Into A Normal Heart Rhythm (Cardioversion) — Completed
• NBS10 (Also Known as AMR-001) Versus Placebo Post ST Segment Elevation Myocardial Infarction — Completed
• Registry to Assess Safety for Subjects That Have Completed a Juventas Sponsored HF Protocol Under IND # 14203 — Status unconfirmed